Phase
Condition
Pancreatic Disorders
Pancreatic Cancer
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Histologically confirmed localised PDAC -as determined by the West of ScotlandHepato-Pancreatobiliary (HPB) MDT
Scheduled to undergo RT +/- chemotherapy
18 years of age or older
Measurable disease on imaging
Able to give written informed consent
Patients willing and able to comply with the protocol for the duration of the study
Exclusion
Exclusion Criteria:
Distant metastatic disease
Other severe or uncontrolled systemic disease or evidence of any other significantdisorder or lab finding that makes it undesirable for the patient to participate inthe study, as determined by the treating physician.
History of physical or psychiatric disorder that would prevent informed consent andcompliance with protocol
Major surgery within 28 days prior to trial entry
Any contraindication to MR
MRI unsafe implants, ferrous metal in the body, insufficient information on previoussurgeries, MRI conditional implants where the conditions cannot be met (e.g.pacemakers).
Study Design
Study Description
Connect with a study center
Beatson West of Scotland Cancer Centre
Glasgow, G120YN
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.